Complement factor H Y402H gene polymorphism and coronary heart disease susceptibility: A meta-analysis

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 2933-2938

  Zhang, Hai Feng ^a   Wang, Jing Feng ^a   Wang, Yan ^b   Zhu, Li Guang ^b   Lei, Lei ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Complement factor H; Coronary heart disease; Gene polymorphism; Meta analysis

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CARDIOVASCULAR RISK; CAUCASIAN; CFH Y402H GENE; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; ONSET AGE; POPULATION GENETICS; RISK FACTOR;

COMPLEMENT FACTOR H; CORONARY DISEASE; DATABASES, FACTUAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 80052443644     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-9956-x     Document Type: Article

References (32)

1. Mathers CD, Loncar D (2006) Projections of global mortality, burden of disease from 2002 to 2030. PLoS Med 3:e442. doi:1371/journal.pmed.0030442
2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:e21-e181. doi:10.1161/circulationaha.108.191261
3. Topol EJ, Smith J, Plow EF, Wang QK (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet Spec 2:R117-R123. doi:10.1093/hmg/ddl183 (Pubitemid 44446784)
4. Watkins H, Farrall M (2006) Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 7:163-173 doi:10.1038/nrg1805 (Pubitemid 43361528)
5. Chen Y, Rollins J, Paigen B, Wang X (2007) Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab 6:164-179. doi:10.1016/j.cmet.2007.07.001 (Pubitemid 47324136)
6. Oksjoki R, Kovanen PT, Pentikainen MO (2003) Role of complement activation in atherosclerosis. Curr Opin Lipidol 5:477-231. doi:10.1097/01.mol. 0000092627.86399.7b
7. de Cordoba SR, Esparza-Gordillo J, de Jorge EG, Lopez-Trascasa M, Sanchez-Corral P (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41:355-367. doi:10.1016/j.molimm.2004.02.005 (Pubitemid 38639887)
8. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, Wade MS, Li Y, Liang L, Zareparsi S, Swaroop A, Abecasis GR (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38:1049-1054. doi:10.1038/ng1871 (Pubitemid 44325931)
9. Shah T, Casas JP, Cooper JA, Tzoulaki I, Sofat R, McCormack V, Smeeth L, Deanfield JE, Lowe GD, Rumley A, Fowkes FG, Humphries SE, Hingorani AD (2009) Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol 38:217-231. doi:10.1093/ije/dyn217
10. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389. doi:10.1126/science.1109557 (Pubitemid 40530070)
11. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van DCM, de Jong PT (2006) Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 296:301-309. doi:10.1001/jama.296.3.301 (Pubitemid 44079314)
12. Donoso LA, Kim D, Frost A, Callahan A, Hageman G (2006) The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 51:137-152. doi:10.1016/j. survophthal.2005.12.001 (Pubitemid 43269939)
13. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT (1995) Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142:404-409
14. 2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162:201-211. doi: 10.1093/aje/kwi184 (Pubitemid 41373524)
15. Steichen T (2001) METANINF: Stata module to evaluate influence of a single study in meta-analysis estimation. Statistical Software Components S419201, Boston College Department of Economics
16. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634 (Pubitemid 27387172)
17. Goverdhan SV, Lotery AJ, Cree AJ, Ye S (2006) Complement factor H Y402H gene polymorphism in coronary artery disease and atherosclerosis. Atherosclerosis 188:213-214. doi:10.1016/ j.atherosclerosis.2006.04.013 (Pubitemid 44142549)
18. Kardys I, Klaver CCW, Despriet DDG, Bergen AAB, Uitterlinden AG, Hofman A, Oostra BA, Van Duijn CM, de Jong PTVM, Witteman JCM (2006) A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam study. J Am Coll Cardiol 47:1568-1575. doi:10.1016/j.jacc.2005.11.076 (Pubitemid 44313826)
19. Zee RYL, Diehl KA, Ridker PM (2006) Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis 187:332-335. doi:10.1016/j.atherosclerosis.2005.09.009 (Pubitemid 43963014)
20. Meng W, Hughes A, Patterson CC, Belton C, Kamaruddin MS, Horan PG, Kee F, McKeown PP (2007) Genetic variants of complement factor H gene are not associated with premature coronary heart disease: a family-based study in the Irish population. BMC Med Genet 8:62. doi:10.1186/1471-2350-8-62 (Pubitemid 350048274)
21. Nicaud V, Francomme C, Ruidavets JB, Luc G, Arveiler D, Kee F, Evans A, Morrison C, Blankenberg S, Cambien F, Tiret L (2007) Lack of association between complement factor H polymorphisms and coronary artery disease or myocardial infarction. J Mol Med 85:771-775. doi:10.1007/s00109-007-0185-2 (Pubitemid 47063529)
22. Pai JK, Manson JE, Rexrode KM, Albert CM, Hunter DJ, Rimm EB (2007) Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. Eur Heart J 28:1297-1303. doi:10.1093/eurheartj/ehm090 (Pubitemid 47355978)
23. Stark K, Neureuther K, Sedlacek K, Hengstenberg W, Fischer M, Baessler A, Wiedmann S, Jeron A, Holmer S, Erdmann J, Schunkert H, Hengstenberg C (2007) The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Clin Sci (Lond) 113:213-218. doi:10.1042/CS20070028 (Pubitemid 47237918)
24. Volcik KA, Ballantyne CM, Braun MC, Coresh J, Mosley TH, Boerwinkle E (2008) Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: the ARIC study. Am J Hypertens 21:533-538. doi:10.1038/ajh.2007.81 (Pubitemid 351589664)
25. Qian Q, Chen Z, Ma G, Jiang Y, Feng Y, Shen C, Yao Y, Ding J, Dai Q, Li Y (2009) Complement factor H Y402H polymorphism, plasma concentration and risk of coronary artery disease. Mol Biol Rep 6:1257-1261. doi:10.1007/s11033-008-9306- 4
26. Pulido JS, McConnell JP, Lennon RJ, Bryant SC, Peterson LM, Berger PB, Somers V, Highsmith WE (2007) Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease. Mayo Clin Proc 82:301-307. doi:10.4065/82.3.301 (Pubitemid 46348931)
27. Koeijvoets KC, Mooijaart SP, Dallinga-Thie GM, Defesche JC, Steyerberg EW, Westendorp RG, Kastelein JJ, van HPM, Sijbrands EJ (2009) Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia. Eur Heart J 30:618-623. doi:10.1093/eurheartj/ ehn568
28. Buraczynska M, Ksiazek P, Zukowski P, Benedyk-Lorens E, Orlowska-Kowalik G (2009) Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients. Clin Immunol 132:285-290. doi:10.1016/j.clim.2009.04.005
29. Greenland S, Robins JM (1985) Confounding misclassification. Am J Epidemiol 122:495-506
30. Zhang HF, Qiu LX, Chen Y, Zhu WL, Mao C, Zhu LG, Zheng MH, Wang Y, Lei L, Shi J (2009) ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls. Hum Genet 125:627-631. doi:10.1007/ s00439-009-0660-7
31. Zhang HF, Zhong BL, Zhu WL, Xie SL, Qiu LX, Zhu LG, Wang Y, Lei L (2009) CD14 C-260T gene polymorphism and ischemic heart disease susceptibility: a HuGE review and meta-analysis. Genet Med 11:403-408. doi:10.1097/gim.0b013e3181a16cb0
32. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J (2004) Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 363:689-695. doi:10.1016/S0140-6736(04)15642-0 (Pubitemid 38296555)